Edesa Biotech
EDSA
10 hedge funds and large institutions have $58K invested in Edesa Biotech in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 8 closing their positions.
0.05% less ownership
Funds ownership: 0.08% → 0.03% (-0.05%)
41% less funds holding
Funds holding: 17 → 10 (-7)
76% less capital invested
Capital invested by funds: $241K → $58K (-$183K)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$33.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$65K |
| 2 |
Jane Street
New York
|
-$28K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$28K |
| 4 |
Millennium Management
New York
|
-$24K |
| 5 |
VF
Virtu Financial
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $45K | +$33.1K | +708 | +151% |
|
|
2
UBS Group
Zurich,
Switzerland
| $12K | +$11.1K | +238 | +290% |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| – | -$65K | -1,116 | Closed |
|
|
5
Jane Street
New York
| – | -$28K | -487 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$28K | -482 | Closed |
|
|
7
Millennium Management
New York
| – | -$24K | -403 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$23K | -389 | Closed |
|
|
RJFSA
9
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$21K | -359 | Closed |
|
10
Goldman Sachs
New York
| – | -$17K | -297 | Closed |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -12 | Closed |
|
|
LC
12
Lindbrook Capital
Calabasas,
California
| – | +$94 | +2 | New |
|
EDSA Hedge Fund Activity: Q4 2018 in Review
10 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2018, worth a combined $58K — down 76% from $241K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of EDSA and 1 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $33.1K. The largest seller was Sabby Management, exiting entirely with an estimated $65K sold.
- 10 institutional investors held Edesa Biotech (EDSA) as of Q4 2018, down from 17 in Q3 2018.
- Funds reported $58K of Edesa Biotech stock for Q4 2018, down 76% quarter-over-quarter.
- 1 fund opened new Edesa Biotech positions in Q4 2018 and 8 closed out, a net change of -7 holders.
- The largest Edesa Biotech buyer in Q4 2018 was Renaissance Technologies, an estimated $33.1K added.
- The largest Edesa Biotech seller in Q4 2018 was Sabby Management, an estimated $65K sold.
Based on aggregated 13F filings for Q4 2018.